F33
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Diagnosis of major depressive disorder (based on DSM-V criteria) -Additionally post-traumatic stress disorder (PTSD), complex PTSD and/or childhood adversity as comorbidity or precedent factor -Written consent after comprehensive study information
Exclusion criteria
Exclusion criteria: -Current substance abuse disorder, schizophrenic disorder, or psychotic depression -Actual suicidality (scores of 4 or 5 in C-SSRS scale) -Cardial instability -Contraindications to MRI, e.g., cardiac pacemaker or ferromagnetic implants -Contraindications to EMDR or EST therapy, such as lack of stability and real world conflicts in the present -Individuals who have started psychotherapy in the last three months -Pregnancy and nursing period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical symptoms of depression measured by MADRS and BDI-II, baseline versus follow-up after 6, 12 and 14 therapy hours | — |
Secondary
| Measure | Time frame |
|---|---|
| -agression (BPAQ, OAS-M, STAXI, LHAS), baseline versus follow-up after 6, 12 and 14 therapy hours -emotion regulation (SRQ, CERQ), baseline versus follow-up after 6, 12 and 14 therapy hours -trauma (CAPS-5) -dysregulation within and between neuronal networks (affective network, salience network, cognitive control network, attention networks) and overexpression of VOCs (e.g. TMA, aceton, butyric acid lactate and others related to energy metabolism, short chain fatty acids, tryptophan metabolism), baseline versus follow-up 14 therapy hours | — |
Countries
Germany
Contacts
Universitätsklinikum Aachen, RWTH Universität Aachen